| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.2M | — | +50.5% |
| Cost of Revenue | $3.6M | — | -27.3% |
| Gross Profit | $11.6M | — | +124.4% |
| R&D Expense | $0 | — | — |
| SG&A Expense | $4.3M | — | -4.3% |
| Operating Income | $6.9M | — | +1979.5% |
| Pre-tax Income | $6.9M | — | +2182.4% |
| Net Income | $6.9M | — | +2182.4% |
| EPS (Basic) | $0.02 | — | — |
| EPS (Diluted) | $0.02 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $36.9M | +108.8% | +36.7% |
| Accounts Receivable | $359K | +90.5% | +768.7% |
| Current Assets | $67.8M | +21.7% | +71.8% |
| Total Assets | $72.2M | +13.2% | +57.5% |
| Current Liabilities | $37.6M | -7.9% | +28.0% |
| Total Liabilities | $38.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $40.7M | — | — |
| Investing Cash Flow | $4.5M | — | +450.8% |
| Financing Cash Flow | -$25.7M | — | -2638.0% |
| +27.8% |
| Stockholders' Equity | $33.6M | +50.0% | +114.6% |